Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NB-UVB with or without topical latanoprost or placebo in vitiligo
IRCT20120215009014N283Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jun 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of latanoprost in Vitiligo (3 arms), sponsored by Hamadan University of Medical Sciences. Started Jun 2019; status: completed.
02
Drugs
latanoprost
03
Conditions
Vitiligo
Beyond the preview
Go deeper on IRCT20120215009014N283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N283.